Dental Products Panel Plaque Subcommittee
This article was originally published in The Tan Sheet
Executive Summary
Will meet Dec. 17-18 to discuss "definitions of various terms and conditions related to dental plaque," "the relationship of dental accumulations to oral diseases," and "the data and information which has been submitted relating to drug and cosmetic labeling for antiplaque products," FDA announces in Nov. 16 Federal Register. The meeting will take place in conference room G of FDA's Parklawn Building, beginning at 9 a.m. both mornings.